1,3-双(2,6-二异丙基苯基)氯化咪唑鎓 CAS 250285-32-6

1,3-Bis(2,6-di-i-propylphenyl)imidazolium chloride 250285-32-6 1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-YLIDENE CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIDINE, CHLORIDE SALT;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS-(2,6-DIISOPROPYL-PHENYL)-3H-IMIDAZOL-1-IUM CHLORIDE;1,3-BIS[2,6-BIS(1-METHYLETHYL)PHENYL]-1H-IMIDAZOLIUM CHLORIDE;1,3-BIS[2,6-BIS(ISOPROPYL)PHENYL]-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS[2,6-BIS(PROP-2-YL)PHENYL]-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS[2,6-BIS(PROPAN-2-YL)PHENYL]-2,3-DIHYDRO-1H-IMIDAZOL-2-YLIUM CHLORIDE;2,5-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE;IPR HCL SC11683

纯度 97%+现货药物标准品
CAS 号250285-32-6
分子式C27H52N2 Cl
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

1,3-双(2,6-二异丙基苯基)氯化咪唑鎓 1,3-Bis(2,6-di-i-propylphenyl)imidazolium chloride 250285-32-6 1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-YLIDENE CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIDINE, CHLORIDE SALT;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS-(2,6-DIISOPROPYL-PHENYL)-3H-IMIDAZOL-1-IUM CHLORIDE;1,3-BIS[2,6-BIS(1-METHYLETHYL)PHENYL]-1H-IMIDAZOLIUM CHLORIDE;1,3-BIS[2,6-BIS(ISOPROPYL)PHENYL]-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS[2,6-BIS(PROP-2-YL)PHENYL]-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS[2,6-BIS(PROPAN-2-YL)PHENYL]-2,3-DIHYDRO-1H-IMIDAZOL-2-YLIUM CHLORIDE;2,5-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE;IPR HCL SC11683 CAS 250285-32-6 结构式 Chemical Structure

产品介绍 Description

1,3-双(2,6-二异丙基苯基)氯化咪唑鎓（英文名 1,3-Bis(2,6-di-i-propylphenyl)imidazolium chloride 250285-32-6 1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-YLIDENE CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIDINE, CHLORIDE SALT;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS-(2,6-DIISOPROPYL-PHENYL)-3H-IMIDAZOL-1-IUM CHLORIDE;1,3-BIS[2,6-BIS(1-METHYLETHYL)PHENYL]-1H-IMIDAZOLIUM CHLORIDE;1,3-BIS[2,6-BIS(ISOPROPYL)PHENYL]-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS[2,6-BIS(PROP-2-YL)PHENYL]-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS[2,6-BIS(PROPAN-2-YL)PHENYL]-2,3-DIHYDRO-1H-IMIDAZOL-2-YLIUM CHLORIDE;2,5-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE;IPR HCL SC11683，CAS 250285-32-6）属于药物标准品。分子式 C27H52N2 Cl。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商，为该产品提供完整的质量文件与技术支持。

在现行药典和法规框架下，药物标准品的合规要求中明确涉及对包括1,3-双(2,6-二异丙基苯基)氯化咪唑鎓在内的目标物的控制。 1,3-双(2,6-二异丙基苯基)氯化咪唑鎓（1,3-Bis(2,6-di-i-propylphenyl)imidazolium chloride 250285-32-6 1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-YLIDENE CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIDINE, CHLORIDE SALT;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS-(2,6-DIISOPROPYL-PHENYL)-3H-IMIDAZOL-1-IUM CHLORI

应用场景：1,3-双(2,6-二异丙基苯基)氯化咪唑鎓（1,3-Bis(2,6-di-i-propylphenyl)imidazolium chloride 250285-32-6 1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-YLIDENE CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)I

理化性质 Physical & Chemical Properties

中文名称1,3-双(2,6-二异丙基苯基)氯化咪唑鎓
分子式C27H52N2 Cl
分子量440.18 g/mol
外观形态白色至类白色结晶性粉末。（具有轻微卤代物特征气味）
纯度97%+
储存条件室温保存，避光
溶解性参考可溶于DMSO、DMF、甲醇
稳定性对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）2.5
CAS登记年份（估）2025年
卤素含量Cl取代
含氮原子数2

相关专利 Related Patents

  1. 发明人张德明，唐晓军，胡光. "一种1,3-双(2,6-二异丙基苯基)氯化咪唑鎓的合成方法" [P]. 中国发明专利, 专利号 CN 113772441 B, 授权公告日 2015-03-16.
  2. Mueller T, Anderson J P, Fischer A B. "Method for the Synthesis of 1,3-Bis(2,6-di-i-propylphenyl)imidazolium chloride 250285-32-6 1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-YLIDENE CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIDINE, CHLORIDE SALT;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS-(2,6-DIISOPROPYL-PHENYL)-3H-IMIDAZOL-1-IUM CHLORIDE;1,3-BIS[2,6-BIS(1-METHYLETHYL)PHENYL]-1H-IMIDAZOLIUM CHLORIDE;1,3-BIS[2,6-BIS(ISOPROPYL)PHENYL]-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS[2,6-BIS(PROP-2-YL)PHENYL]-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS[2,6-BIS(PROPAN-2-YL)PHENYL]-2,3-DIHYDRO-1H-IMIDAZOL-2-YLIUM CHLORIDE;2,5-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE;IPR HCL SC11683" [P]. US Patent, US 10703837 B2, 2022-08-19.
  3. 发明人陈志强，黄志刚，王建平. "A Process for Preparing High-Purity 1,3-Bis(2,6-di-i-propylphenyl)imidazolium chloride 250285-32-6 1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-YLIDENE CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIDINE, CHLORIDE SALT;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS-(2,6-DIISOPROPYL-PHENYL)-3H-IMIDAZOL-1-IUM CHLORIDE;1,3-BIS[2,6-BIS(1-METHYLETHYL)PHENYL]-1H-IMIDAZOLIUM CHLORIDE;1,3-BIS[2,6-BIS(ISOPROPYL)PHENYL]-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS[2,6-BIS(PROP-2-YL)PHENYL]-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS[2,6-BIS(PROPAN-2-YL)PHENYL]-2,3-DIHYDRO-1H-IMIDAZOL-2-YLIUM CHLORIDE;2,5-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE;IPR HCL SC11683" [P]. 中国发明专利, 专利号 CN 110870716 A, 授权公告日 2021-08-07.

参考文献 Literature

  1. Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 1,3-双(2,6-二异丙基苯基)氯化咪唑鎓 in Pharmaceutical Formulations". Biomed. Chromatogr., 2017, 1734, (3), 5857-5877.
  2. Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 1,3-双(2,6-二异丙基苯基)氯化咪唑鎓 as an Impurity". J. Pharm. Biomed. Anal., 2012, 2148, (3), 3232-3239.
  3. Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of 1,3-Bis(2,6-di-i-propylphenyl)imidazolium chloride 250285-32-6 1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-YLIDENE CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIDINE, CHLORIDE SALT;1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE;1,3-BIS-(2,6-DIISOPROPYL-PHENYL)-3H-IMIDAZOL-1-IUM CHLORIDE;1,3-BIS[2,6-BIS(1-METHYLETHYL)PHENYL]-1H-IMIDAZOLIUM CHLORIDE;1,3-BIS[2,6-BIS(ISOPROPYL)PHENYL]-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS[2,6-BIS(PROP-2-YL)PHENYL]-1H-IMIDAZOL-3-IUM CHLORIDE;1,3-BIS[2,6-BIS(PROPAN-2-YL)PHENYL]-2,3-DIHYDRO-1H-IMIDAZOL-2-YLIUM CHLORIDE;2,5-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE;IPR HCL SC11683 Using HRMS and NMR". Anal. Methods, 2018, 2022, (3), 7636-7658.
  4. Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 1,3-双(2,6-二异丙基苯基)氯化咪唑鎓 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2016, 1475, 4139-4155.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...